Skip to main content
. 2020 Jun 1;39(2):176–185. doi: 10.1007/s12664-020-01047-6

Fig. 1.

Fig. 1

Flow diagram showing inclusion of participants for further analysis. IBD inflammatory bowel disease, TNF tumor necrosis factor, TDM therapeutic drug monitoring